Corrigendum to "Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity" [Mol Metab 78 (2023) 101801]
Saved in:
Main Authors: | Martin Haljeta Friedrichsen (Author), Lars Endahl (Author), Frederik Flindt Kreiner (Author), Ronald Goldwater (Author), Martin Kankam (Author), Søren Toubro (Author), Sune Boris Nygård (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity
by: Martin Haljeta Friedrichsen, et al.
Published: (2023) -
Corrigendum to "Interactions between metabolism and chromatin in plant models" [Mol Metab 38 (Aug 2020) 100951]
by: Christian Lindermayr, et al.
Published: (2020) -
Erratum to "Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock" [Mol Metab 3 (2014) 29-41]
by: Kenneth A. Dyar, et al.
Published: (2014) -
Corrigendum to "Nuclear Factor-Y is an adipogenic factor that regulates leptin gene expression"[Mol Metab 4 (2015) 392-405]
by: Yi-Hsueh Lu, et al.
Published: (2015) -
Corrigendum to "Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha" [Mol Metab 7 (2018) 80-89]
by: Guolin Li, et al.
Published: (2018)